48 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compound.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Universidade Federal De Goi£S
Novel, potent, and selective quinoxaline-based 5-HT(3) receptor ligands. 1. Further structure-activity relationships and pharmacological characterization.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
European Research Centre For Drug Discovery and Development (Natsyndrugs)
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Universit£
Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Universit£
Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Abbott Laboratories
3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873).![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Hoechst-Roussel Pharmaceuticals
Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Smithkline Beecham Pharmaceuticals
(5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431).![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Abbott Laboratories
The serotonin 5-HT4 receptor. 1. Design of a new class of agonists and receptor map of the agonist recognition site.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Sandoz Pharma
3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Universit£
Synthesis and hypoglycemic activity of substituted 8-(1-piperazinyl)imidazo[1,2-a]pyrazines.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Merck Sharp and Dohme Research Laboratories
Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Pfizer
Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivatives.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
Specific targeting of peripheral serotonin 5-HT(3) receptors. Synthesis, biological investigation, and structure-activity relationships.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
European Research Centre For Drug Discovery and Development (Natsyndrugs)
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Dipartimento Di Scienze Farmaceutiche
An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Predix Pharmaceuticals
Nanomolar inhibitors of CNS epinephrine biosynthesis: (R)-(+)-3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines as potent and highly selective inhibitors of phenylethanolamine N-methyltransferase1.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
University of Kansas
Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigation.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Virginia Commonwealth University
Alpha(2) adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-imidazo)-1,3-dimethyl-6,7-dihydro-thianaphthene as a high-affinity ligand for the alpha(2D) adrenergic receptor.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
The R. W. Johnson Pharmaceutical Research Institute
alpha(2) Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-Imidazo)-1,3-dimethyl-6,7-dihydrothianaphthene [corrected] as a high-affinity ligand for the alpha(2D) adrenergic receptor.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
The R. W. Johnson Pharmaceutical Research Institute
Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Warner-Lambert
N-Substituted (2,3-dihydro-1,4-benzodioxin-2-yl)methylamine derivatives as D(2) antagonists/5-HT(1A) partial agonists with potential as atypical antipsychotic agents.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Knoll Pharmaceuticals
7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics. 2. Pharmacological profile of 7-[3-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)-piperidin-1-yl]propoxy]-3-(hydroxymeth yl)chromen -4-one (abaperidone, FI-8602).![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Centro De InvestigacióN Grupo Ferrer
Isoindolinone enantiomers having affinity for the dopamine D4 receptor.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Parke-Davis Pharmaceutical Research
Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonists.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Warner-Lambert
Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Solvay Duphar
Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Smithkline Beecham Pharmaceuticals
(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinity.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Sandoz Pharma
N-(1,3,4,6,7,12b-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin -2-yl)-N- methyl-2-hydroxyethane-sulfonamide: a potent and selective alpha 2-adrenoceptor antagonist.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
Structure-affinity relationships of arylquinolizines at alpha-adrenoceptors.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Merck Sharp & Dohme Research Laboratories
2H-[1]benzopyrano[3,4-b]pyridines: synthesis and activity at central monoamine receptors.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Ciba-Geigy
Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Columbia University
Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Kyowa Hakko Kogyo
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Institut De Recherches Servier
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Institut De Recherches Servier
OPC-28326, a selective femoral vasodilator, is an alpha2C-adrenoceptor-selective antagonist.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Otsuka Maryland Research Institute
Rabbit alpha2-adrenoceptors: both platelets and adipocytes have alpha2A-pharmacology.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Glaxosmithkline
S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Centre De Recherches De Croissy
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Centre De Recherches De Croissy
Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Institut De Recherches Servier
Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Syntex Discovery Research
Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
University of Nebraska
Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
University of Nebraska
SDZ 205-557, a selective, surmountable antagonist for 5-HT4 receptors in the isolated guinea pig ileum.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Sandoz Pharma